Masaru Kurebe

682 citations
44 papers · 569 indexed · h-index 13
Topics
Cancer therapeutics and mechanisms (9 papers)Antibiotics Pharmacokinetics and Efficacy (7 papers)Bioactive Compounds and Antitumor Agents (5 papers)
Partner nations
JapanUnited States

In The Last Decade

Masaru Kurebe

42 papers receiving 544 citations

Peers

Masaru Kurebe
Comparison fields: 5 of 100
  • Molecular Biology 221
  • Spectroscopy 95
  • Materials Chemistry 95
  • Oncology 84
  • Cellular and Molecular Neuroscience 54
Replace Saburou Matsuo with:
Saburou Matsuo Japan
Kaori Ueda Japan
Yukari Nakamura Japan
John F. Hackney United States
Weihan Wang China
Masaki Nakatani Japan
Jin Guo China
Yanying Chen China
Kiminori Miyazaki Japan
R. Demeure Belgium
Masaru Kurebe relative to Saburou Matsuo Japan Saburou Matsuo's profile →
Citations per field
00.5×1.5×
Saburou Matsuo · 1×
Citations per year

Countries citing papers authored by Masaru Kurebe

Since Specialization
Citations

This map shows the geographic impact of Masaru Kurebe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaru Kurebe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaru Kurebe more than expected).

Fields of papers citing papers by Masaru Kurebe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaru Kurebe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaru Kurebe. The network helps show where Masaru Kurebe may publish in the future.

Co-authorship network of co-authors of Masaru Kurebe

This figure shows the co-authorship network connecting the top 25 collaborators of Masaru Kurebe. A scholar is included among the top collaborators of Masaru Kurebe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaru Kurebe. Masaru Kurebe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 24
3 21
4 23
5 41
6 2
7 6
8 29
9 98
10 44
11 25
12 2
13 3
14 2
15 20
16
Toxicological studies on (2"R)-4'-O-tetrahydropyranyladriamycin, a new antitumor antibiotic. Its subacute toxicity in male beagle dogs.
1
17
[Effect of fosfomycin on auditory organs and its transfer to cochlear lymph following application of its solution into a middle ear cavity].
6
18 3
19 5
20 6

About Masaru Kurebe

Masaru Kurebe is a scholar working on Toxicology, Pharmacology and Pharmacology, having authored 44 papers that have together received 569 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (9 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Bioactive Compounds and Antitumor Agents (5 papers). The work is most often cited by research in Spectroscopy (95 citations), Bioengineering (24 citations) and Developmental Neuroscience (16 citations). Masaru Kurebe has collaborated with scholars based in Japan and United States. Frequent co-authors include Ken-ichi Kiyomiya, Saburou Matsuo, Hiroshi Nakagawa, Sadashige Matsuo, Inmaculada Silos‐Santiago, Kojiro Kurisu, Tetsuichiro Inai, Yoshihisa Nakano, Junko Matsuzaki and Hiroyuki Ichikawa. Their work appears in journals such as Biochemical and Biophysical Research Communications, Neuroscience and Journal of Nutrition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026